Article Text
PostScript
Letter
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus—authors' response
Statistics from Altmetric.com
Footnotes
Contributors YR and AJS wrote the text jointly.
Funding National Institute of Diabetes and Digestive and Kidney Diseases (Intramural Research Program).
Competing interests AS: Consultant for Echosens-Sandhil and Sequana.
Provenance and peer review Not commissioned; internally peer reviewed.